Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens

Author/s	Pachón Ibáñez, María Eugenia Docobo Pérez, Fernando Blanquero Bravo, Rafael Garnacho Montero, José Benítez Peña, Sandra Dimopoulos, George Rosso Fernández, Clara Gutiérrez Pizarraya, Antonio López Cortés, Luis Fernando Cisneros Herreros, José Miguel
Department	Universidad de Sevilla. Departamento de Estadística e Investigación Operativa
Date	2016
Published in	26th European Congress of Clinical Microbiology and Infectious Diseases (2016).
Abstract	The objective of this study was to characterize the pharmacokinetics of colistin methanesulphonate (CMS) and colistin in critically ill patients following the administration of a 4.5 MU CMS loading dose follow by 3MU CMS ...
Citation	Pachón Ibáñez, M.E., Docobo Pérez, F., Blanquero Bravo, R., Garnacho Montero, J., Benítez Peña, S., Dimopoulos, G.,...,Cisneros Herreros, J.M. (2016). Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens. En 26th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam.